FDA's No. 2 Amy Aber­nethy to leave the agency in April

The FDA’s prin­ci­pal deputy com­mis­sion­er of food and drugs and act­ing chief in­for­ma­tion of­fi­cer, Amy Aber­nethy, will leave the agency in mid-to-late April, ac­cord­ing to a sur­prise memo on Tues­day from Janet Wood­cock, the act­ing FDA com­mis­sion­er.

Aber­nethy’s sud­den de­par­ture comes a lit­tle more than two years since she joined the FDA, af­ter mak­ing the jump to pub­lic ser­vice from her post as chief med­ical of­fi­cer, chief sci­en­tif­ic of­fi­cer, and se­nior vice pres­i­dent for on­col­o­gy at Roche’s Flat­iron Health.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER